Abstract
The administration of Sedormid (2-isopropylpent-4-enoylurea) to rabbits resulted in an experimental porphyria (Schmid and Schwartz, 1952) and the liver which was shown to be the major site of the metabolic disturbance contained large amounts of uro-, copro-, and proto-porphyrin. Sedormid (Fig. 1 a) has a structure closely similar to the barbiturate group of drugs (Fig. 1 b). Investigation of the relationship between structure and porphyrin inducing activity revealed the following requirements for activity: an allyl group together with either a cyclic ureide (as in the barbiturates), a ureide (as in Sedormid), or an acid amide [as in allylisopropylacetamide (AIA, Fig. 1 c)].
This work was supported by a grant from the Medical Research Council, Canada.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abbritti, G., De Matteis, F.: Decreased levels of cytochrome P-450 and catalase in hepatic porphyria caused by substituted acetamides and barbiturates. Importance of the allyl group in the molecule of the active drugs. Chem. biol. Interact. 4, 281–286 (1971)
Atsmon, A.: Personal communication (1975)
Atsmon, A., Blum, I.: Treatment of acute porphyria variegata with propranolol. Lancet 1970 I,196–197
Blum, I., Schoenfeld, N., Atsmon, A.: The effect of DL-propranolol on δ-aminolevulinic acid synthetase activity and urinary excretion of porphyrins in allylisopropylacetamide-induced experimental porphyria. Biochim. biophys. Acta (Amst.) 320, 242–248 (1973)
Brodie, B.B., Cosmides, G.J., Rail, D.P.: Toxicology and the biomedical sciences. Science 148, 1547–1554 (1965)
Cowger, M.L., Labbe, R.F.: Contraindications of biological oxidation inhibitors in the treatment of porphyria. Lancet 1965 I, 88–89
Creighton, J.M., Marks, G.S.: Drug-induced porphyrin biosynthesis—I. The effect of porphyria-inducing drugs on N-demethylase activity of chick embryo liver. Biochem. Pharmacol. 18, 2040–2045 (1969)
Creighton, J.M., Marks, G.S.: Drug-induced porphyrin biosynthesis—VII. Species, sex, and developmental differences in the generation of experimental porphyria. Canad. J. Physiol. Pharmacol. 50, 485–489 (1972)
Dean, G.: A report on propanidid, an intravenous anaesthetic in Porphyria variegata. S. Afr. med. J. 43, 227–229 (1969)
Dean, G.: The Porphyrins. 2nd ed., p. 132. Philadelphia — Montreal: J.B. Lippincott Co. 1971
De Matteis, F.: Drugs and porphyria, S. Afr. J. Lab. clin. Med. 17, 126–133 (1971)
De Matteis, F.: Disturbances of liver porphyrin metabolism caused by drugs. Pharmacol. Rev. 19, 523–557 (1967)
De Matteis, F.: Drug interactions in experimental hepatic porphyria. A model for the exacerbation by drugs of human variegate porphyria. Enzyme 16, 266–275 (1973)
De Matteis, F., Abbritti, G., Gibbs, A.H.: Decreased liver activity of porphyrin-metal chelatase in hepatic porphyria caused by 3,5-diethoxycarbonyl-l,4-dihydrocollidine. Biochem. J. 134, 717–727 (1973)
Doss, M., Kaltepoth, B.: Porphyrin biosynthesis in liver cell cultures. S. Afr. J. Lab. clin. Med. 17, 73–75 (1971)
Eales, L.: Acute porphyria: The precipitating and aggravating factors. S. Afr. J. Lab. clin. Med. 17, 120–125 (1971)
Edwards, A.M., Elliott, W.H.: Induction of δ-aminolevulinic acid synthetase in isolated rat liver cell suspensions. Adenosine 3′:5′-monophosphate dependence of induction by drugs. J. biol. Chem. 249, 851–855 (1974)
Edwards, A.M., Elliott, W.H.: Induction of 8-aminolevulinic acid synthetase in isolated rat liver cells by steroids. J. biol. Chem. 250, 2750–2755 (1975)
Finkelstein, R.A.: Observations on mode of action of endotoxin in chick embryos. Proc. Soc. exp. Biol. (N.Y.) 115, 702–707 (1964)
Fischer, P.W.F., Morgan, R.O., Krupa, V., Marks, G.S.: Drug-induced porphyrin biosynthesis—XV. Induction of porphyrin biosynthesis in chick embryo liver cells maintained in serum-free Waymouth medium. Biochem. Pharmacol. 25, 687–693 (1976)
Goldberg, A.: The effects of certain barbiturates on the porphyrin metabolism of rabbits. Biochem. J. 57, 55–61 (1954)
Goldberg, A., Rimington, C.: Experimentally produced porphyria in animals. Proc. roy. Soc. B 143, 257–280 (1955)
Granick, S.: A test for detection of porphyria-inducing drugs. J. Amer. med. Ass. 190, 475 (1964)
Granick, S.: The induction in vitro of the synthesis of δ-aminolevulinic acid synthetase in chemical porphyria: A response to certain drugs, sex hormones and foreign chemicals. J. biol. Chem. 241, 1359–1375 (1966)
Granick, S., Kappas, A.: Steroid control of porphyrin and heme biosynthesis: A new biological function of steroid hormone metabolites. Proc. nat. Acad. Sci. (Wash.) 57, 1463–1467 (1967a)
Granick, S., Kappas, A.: Steroid induction of porphyrin synthesis in liver cell culture. I. Structural basis and possible physiological role in the control of heme formation. J. biol. Chem. 24, 4587–4593 (1967b)
Granick, S., Sassa, S.: δ-Aminolevulinic acid synthetase and the control of heme and chlorophyll synthesis. In: Metabolic Regulation. Vogel H.J. (ed.), Vol. 5 of Metabolic Pathways, pp. 77–141. New York–London: Academic Press 1971
Granick, S., Sinclair, P., Sassa, S., Grieninger, G.: Effects by heme, insulin, and serum albumin on heme and protein synthesis in chick embryo liver cells cultured in a chemically defined medium, and a spectrofluorometric assay for porphyrin composition. J. biol. Chem. 250, 9215–9225 (1975)
Gross, S.R., Hutton, J.J.: Induction of hepatic δ-aminolevulinic acid synthetase activity in strains of inbred mice. J. biol. Chem. 246, 606–614 (1971)
Hansch, C.: Quantitative relationships between lipophilic character and drug metabolism. Drug Metab. Rev. 1, 1–14 (1972)
Hansch, C., Clayton, J.M.: Lipophilic character and biological activity of drugs II: The parabolic case. J. pharm. Sci. 62, 1–21 (1973)
Hansch, C., Dunn, W.J.: Linear relationship between lipophilic character and biological activity of drugs. J. pharm. Sci. 61, 1–19 (1972)
Hansch, C., Steward, A.R., Anderson, S.M., Bentley, D.: The parabolic dependence of drug action upon lipophilic character as revealed by a study of hypnotics. J. med. Chem. 11, 1–11 (1968)
Hayashi, N., Kurashima, Y., Kikuchi, G.: Mechanism of allylisopropylacetamide-induced increase of δ-aminolevulinate synthetase in liver mitochondria. V. Mechanism of regulation by hemin of the level of δ-aminolevulinate synthetase in rat liver mitochondria. Arch. Biochem. Biophys. 148, 10–21 (1972).
Heymann, E., Krisch, K., Buch, H., Buzello, W.: Inhibition of phenacetin- and acetanilide-induced methemoglobinemia in the rat by the carboxylesterase inhibitor bis-[p-nitrophenyl] phosphate. Biochem. Pharmacol. 18, 801 -811 (1969)
Hirsch, G.H., Bubbar, G.L., Marks, G.S.: Studies of the relationship between chemical structure and porphyria-inducing activity—III. Biochem. Pharmacol. 16, 1455–1462 (1967)
Hirsch, G.H., Gillis, J.D., Marks, G.S.: Studies of the relationship between chemical structure and porphyria-inducing activity—II. Biochem. Pharmacol. 15, 1006–1008 (1966)
Hutton, J.J., Gross, S.R.: Chemical induction of hepatic porphyria in inbred strains of mice. Arch. Biochem. Biophys. 141, 284–292 (1970)
Jacob, F., Monod, J.: Genetic regulatory mechanisms in the synthesis of proteins. J. molec. Biol. 3, 318–356 (1961)
Kappas, A., Granick, S.: Steroid induction of porphyrin synthesis in liver cell culture II. The effects of heme, uridine diphosphate glucuronic acid, and inhibitors of nucleic acid and protein synthesis on the induction process. J. biol. Chem. 243, 346–351 (1968)
Kappas, A., Song, C.S., Levere, R.D., Sachson, R.A., Granick, S.: The induction of δ-aminolevulinic acid synthetase in vivo in chick embryo liver by natural steroids. Proc. nat. Acad. Sci. (Wash.) 61, 509–513 (1968)
Koskelo, P., Eisalo, A., Toivonen, I.: Urinary excretion of porphyrin precursors and coproporphyrin in healthy females on oral contraceptives. Brit. med. J. 1966 I, 652–654
Krisch, K.: Carboxylic ester hydrolases. In: The Enzymes 3rd ed., Vol. 5, edit, by P.D. Boyer, pp. 43–69. New York — London: Academic Press 1972
Krupa, V., Blattei, R.A., Marks, G.S.: Drug-induced porphyrin biosynthesis—IX. Levels of 14C-allylisopropylacetamide, 14C-propylisopropylacetamide and metabolite(s) in the livers of chick embryos and mice. Enzyme 16, 276–285 (1973)
Krupa, V., Creighton, J.C., Freeman, M., Marks, G.S.: Drug-induced porphyrin biosynthesis—XII. Levels of cytochrome P-450 in chick embryo liver following administration of allylisopropylacetamide and propylisopropylacetamide. Canad. J. Physiol. Pharmacol. 52, 891–895 (1974)
Leo, A., Hansch, C., Elkins, D.: Partition coefficients and their uses. Chem. Rev. 71, 525–616 (1971)
Marks, G.S.: Unpublished observations (1975)
Marks, G.S., Hunter, E.G., Terner, U.K., Schneck, D.: Studies of the relationship between chemical structure and porphyria-inducing activity. Biochem. Pharmacol. 14, 1077–1084 (1965)
Marks, G.S., Krupa, V., Murphy, F., Taub, H., Blattei, R.A.: Mechanisms of drug-induced porphyrin biosynthesis. Ann. N.Y. Acad. Sci. 244, 472–480 (1975)
Marks, G.S., Krupa, V., Roomi, M.W.: Drug-induced porphyrin biosynthesis—VIII. Investigation of the importance of an allyl group for activity in substituted acetamides. Canad. J. Physiol. Pharmacol. 51, 863–868 (1973)
Meyer, U.A., Strand, L.J., Doss, M., Rees, A.C., Marver, H.S.: Intermittent acute porphyria-demonstration of a genetic defect in porphobilinogen metabolism. New Engl. J. Med. 286, 1277–1282 (1972)
Moore, M.R., Battistini, V., Beattie, A.D., Goldberg, A.: The effects of certain barbiturates on the hepatic porphyrin metabolism of rats. Biochem. Pharmacol. 19, 751–757 (1970)
Morgan, R.O., Fischer, P.W.F., Marks, G.S.: Unpublished observations (1976)
Morgan, R.O., Fischer, P.W.F., Stephens, J.K., Marks, G.S.: Thyroid hormone enhancement of drug-induced porphyrin biosynthesis in chick embryo liver cells maintained in serum-free Waymouth medium. Biochem. Pharmacol. 25, 2609–2612 (1976)
Murphy, F.R., Krupa, V., Marks, G.S.: Drug-induced porphyrin biosynthesis—XIII. Role of lipophilicity in determining porphyrin-inducing activity of aliphatic amides after blockade of their hydrolysis by bis-[p-nitrophenyl] phosphate. Biochem. Pharmacol. 24, 883–889 (1975)
Murphy, F.R., Krupa, V., Marks, G.S.: Drug-induced porphyrin biosynthesis—XIV. Role of lipophilicity in determining porphyrin-inducing activity of esters and amides following blockade of their hydrolysis by bis-[p-nitrophenyl) phosphate. Biochem. Pharmacol. 25, 1351–1354 (1976)
Murthy, V.V., Woods, J.S.: Solubilization and partial purification of mitochondrial δ-aminolevulinate synthase from fetal rat liver. Biochim. biophys. Acta (Amst.) 350, 240–246 (1974)
Nebert, D.W., Gelboin, H.V.: The role of ribonucleic acid and protein synthesis in microsomal aryl hydrocarbon hydroxylase induction in cell cultures: The independence of transcription and translation. J. biol. Chem. 245, 160–168 (1970)
Ohashi, A., Kikuchi, G.: Mechanism of allylisopropylacetamide-induced increase of δ-aminolevulinate synthetase in liver mitochondria. VI. Multiple molecular forms of δ-aminolevulinate synthetase in the cytosol and mitochondria of induced cock liver. Arch. Biochem. Biophys. 153, 34–46 (1972)
Peterkofsky, B., Tomkins, G.M.: Evidence for the steroid-induced accumulation of tyrosine aminotransferase messenger RNA in the absence of protein synthesis. Proc. nat. Acad. Sci. (Wash.) 60, 222–228 (1968)
Poland, A., Glover, E.: 2,3,7,8-Tetrachlorodibenzo-p-dioxin: A potent inducer of δ-aminolevulinic acid synthetase. Science 179, 476–477 (1973a)
Poland, A., Glover, E.: Chlorinated dibenzo-p-dioxins: Potent inducers of δ-aminolevulinic acid synthetase and aryl hydrocarbon hydroxylase. II. A study of the structure-activity relationship. Molec. Pharmacol. 9, 736–747 (1973b)
Racz, W.J., Marks, G.S.: Drug-induced porphyrin biosynthesis—II. Simple procedure for screening drugs for porphyria-inducing activity. Biochem. Pharmacol. 18, 2009–2018 (1969)
Racz, W.J., Marks, G.S.: Drug-induced porphyrin biosynthesis—IV. Investigation of the differences in response of isolated liver cells and the liver of the intact chick embryo to porphyria-inducing drugs. Biochem. Pharmacol. 21, 143–151 (1972)
Racz, W.J. Moffat, J.A.: Drug metabolism in cell culture—I. Importance of steric factors for activity in porphyrin-inducing drugs. Biochem. Pharmacol. 23, 215–221 (1974)
Rifkind, A.B., Gillette, P.N. Song, C.S., Kappas, A.: Induction of hepatic δ-aminolevulinic acid synthetase by oral contraceptive steroids. J. clin. Endocr. 30, 330–335 (1970)
Rifkind, A.B., Gillette, P.N., Song, C.S., Kappas, A.: Drug stimulation of δ-aminolevulinic acid synthetase and cytochrome P-450 in vivo in chick embryo liver. J. Pharmacol, exp. Ther. 185, 214–225 (1973)
Sassa, S., Granick, S.: Induction of δ-aminolevulinic acid synthetase in chick embryo liver cells in culture. Proc. nat. Acad. Sci. (Wash.) 67, 517–522 (1970)
Schlesinger, F.G., Gastel (van), C.: Possible aggravation of abdominal symptoms by tolbutamide in a patient with diabetes and hepatic porphyria. Acta med. scand. 169, 433–435 (1961)
Schmid, R., Schwartz, S.: Experimental porphyria III. Hepatic type produced by Sedormid. Proc. Soc. exp. Biol. (N.Y.) 81, 685–689 (1952)
Schneck, D.W., Marks, G.S.: The inhibition of drug-induced porphyria by hemin. Pharmacologist 11, 285 (1969)
Schneck, D.W., Racz, W.J., Hirsch, G.H., Bubbar, G.L., Marks, G.S.: Studies of the relationship between chemical structure and porphyria-inducing activity—IV. Investigations in a cell culture system. Biochem. Pharmacol. 17, 1385–1399 (1968)
Sinclair, P.R., Granick, S.: Uroporphyrin formation induced by chlorinated hydrocarbons (lindane, polychlorinated biphenyls, tetrachlorodibenzo-p-dioxin). Requirements for endogenous iron, protein synthesis and drug-metabolizing activity. Biochem. biophys. Res. Commun. 61, 124–133 (1974)
Song, C.S., Bonkowsky, H.L., Tschudy, D.P.: Salicylamide metabolism in acute intermittent porphyria. Clin. Pharmacol. Ther. 15, 431–435 (1974)
Song, C.S., Singer, J.W., Levere, R.D., Harris, D.F., Kappas, A.: Developmental and gestational influences on drug induction of 5-aminolevulinic acid (ALA) synthetase in rat liver. J. Lab. clin. Med. 72, 1019–1020 (1968)
Stich, W., Decker, P.: Studies on the mechanism of porphyrin biosynthesis with the aid of inhibitors. In: Ciba Foundation Symposium on Porphyrin Biosynthesis and Metabolism. Wolstenholme, G.E.W. Miller and Miller, E.C.P. (eds.), pp. 254–260. London: J. and A. Churchill 1955
Strand, L.J., Manning, J., Marver, H.S.: The induction of δ-aminolevulinic acid synthetase in cultured liver cells. The effects of end product and inhibitors of heme synthesis. J. biol. Chem. 247, 2820–2827 (1972)
Strik, J.J.T.W.A.: Chemical porphyria in Japanese quail (Coturnix c. Japonka). Enzyme 16, 211–223 (1973)
Strik, J.J.T.W.A., Wit, J.G.: Hepatic porphyria in birds and mammals. TNO-nieuws 27, 604–610 (1972)
Strittmatter, C.F., Umberger, F.T.: Oxidative enzyme components of avian liver microsomes. Changes during embryonic development and the effects of phenobarbital administration. Biochim. biophys. Acta (Amst.) 180, 18–27 (1969)
Talman, E.L., Labbe, R.F., Aldrich, R.A.: Porphyrin metabolism. IV. Molecular structure of acetamide derivatives affecting porphyrin metabolism. Arch. Biochem. Biophys. 66, 289–300 (1957)
Taub, H.: Drug-induced porphyrin biosynthesis. Effects of lipophilicity and hepatic metabolism on the porphyria-inducing activity of sedative-hypnotic drugs. M. Sc. Thesis, Queen’s University, Kingston, Canada (1973)
Taub, H., Krupa, V., Marks, G.S.: Drug-induced porphyrin biosynthesis—XI. Effect of SKF 525-A on the activity of porphyrin-inducing drugs in chick embryos, chickens and rats. Biochem. Pharmacol. 25, 511–516 (1976)
Taub, H., Marks, G.S.: Drug-induced porphyrin biosynthesis—X. Potentiation of propanidid-induced elevation of δ-aminolevulinic acid synthetase and porphyrins in chick embryo liver by the carboxylesterase inhibitor bis-[p-nitrophenyl] phosphate. Canad. J. Physiol. Pharmacol. 51, 700–704 (1973)
Tomita, Y., Ohashi, A., Kikuchi, G.: Induction of δ-aminolevulinate synthetase in organ culture of chick embryo liver by allylisopropylacetamide and 3,5-dicarbethoxy-l,4-dihydro-collidine. J. Biochem. 75, 1007–1015 (1974)
Tyrrell, D.L.J., Marks, G.S.: Drug-induced porphyrin biosynthesis—V. Effect of protohemin on the transcriptional and post-transcriptional phases of 8-aminolevulinic acid synthetase induction. Biochem. Pharmacol. 21, 2077–2093 (1972)
Vos, J.G., Botterweg, P.F., Strik, J.J.T.W.A., Koeman, J.H.: Experimental studies with HCB in birds. TNO-news, 27, 599–603 (1972)
Watson, C.J.: Pursuit of the purple. J. Amer. med. Ass. 197, 1074–1080 (1966)
Watson, C.J.: Private communication (1974)
Woods, J.S., Dixon, R.L.: Neonatal differences in the induction of hepatic aminolevulinic acid synthetase. Biochem. Pharmacol. 19, 1951–1954 (1970a)
Woods, J.S., Dixon, R.L.: Perinatal differences in delta-aminolevulinic acid synthetase activity. Life Sci. 9, 711–719 (1970b)
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1978 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Marks, G.S. (1978). The Effect of Chemicals on Hepatic Heme Biosynthesis. In: De Matteis, F., Aldridge, W.N. (eds) Heme and Hemoproteins. Handbuch der experimentellen Pharmakologie / Handbook of Experimental Pharmacology, vol 44. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-66763-3_7
Download citation
DOI: https://doi.org/10.1007/978-3-642-66763-3_7
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-66765-7
Online ISBN: 978-3-642-66763-3
eBook Packages: Springer Book Archive